Switzerland · Series B startup
Funding summaryUpdated 26 Oct 2026
$352Mraised across 10 rounds since 2000, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding record
Novartis Venture Fund
Aravis Ventures
BZ Bank
Pictet Private Equity Investors S.A.From a historical funding record
Novartis Venture FundAravis VenturesBZ BankPictet Private Equity Investors S.A.Reported by onbiovc.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
BZ BankNovartis Venture FundLODH Immunology FundAravis VenturesPictet Private Equity Investors S.A.Ingro Finanz AGVaruma AG
Rosetta CapitalMissing a round, or an investor who was in one? Tell us.
NovImmune's investors include BZ Bank, Novartis Venture Fund, LODH Immunology Fund, Aravis Ventures and Pictet Private Equity Investors S.A., and 3 more on record.
NovImmune has raised $352M across 10 rounds since 2000.
NovImmune's most recent round was a Series B of $66M in Feb 2014.
Its most recent round, $66M in Feb 2014, is also its largest on record.
NovImmune's first round on record, in May 2000, was backed by Novartis Venture Fund and LODH Immunology Fund.
NovImmune's latest named round is a Series B, in Feb 2014.
NovImmune is based in Switzerland.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland · 
